Shanxi Kangbao Biological Product Co., Ltd.

This early-stage study tested the safety of a new injectable drug called LP-98 in people recently diagnosed with HIV who had not yet started standard treatment. Forty participants received different doses of the drug via injection every two weeks for about two months. The main go…

This study tested a new weekly injection called Lipovirtide, given alongside standard daily pills, to control HIV in people who had never been treated before. It involved 64 participants and aimed to find the most effective and safe dose. The main goal was to see how well the com…